|
Industry Pharmacogenomics Working Group (I-PWG) |
|
I-PWG is a voluntary and informal association of pharmaceutical companies engaged in research in the science of pharmacogenomics. The Group’s discussions, activities and programs are open and transparent. They are limited exclusively to non-competitive matters. I-PWG member companies
Abbott, Amgen, Biogen Idec, Bristol-Myers Squibb, Eisai, EliLilly, Genentech, Johnson & Johnson, Merck, Millenium, Novartis,Orion Pharma, Roche, Sanofi Aventis, Schering-Plough, TevaPharmaceutical, Wyeth Pharmaceuticals |
|
|
download an Informational brochure |
|
Download an Informational Brochure intended for IRBs/IECs and Investigational Site Staff involved in clinical trials having a pharmacogenomic (DNA) component.
The brochure
describes the added value of pharmacogenomic research in pharmaceutical drug
development.
Topics covered include, informed consent, return of genetic data to subjects, privacy/confidentiality, and sample coding methods.
The brochure is also available as a web page on this site.
|
|
|
